A €135 Million EU Grant and a New Electrolyser Are Nel ASA's Best Hope to Bridge the Gap Between Rally and Reality

Nel ASA shares rally 56% YTD but Q1 revenue falls 5% and orders plunge 73%; EU grant and July half-year results critical to closing gap between market euphoria and analyst caution.

This week’s calendar is packed with macro data that could make or break the case for big-ticket hydrogen projects. The Federal Reserve will release minutes from its April meeting on Wednesday, offering clues on interest rate trajectory – a direct lever on the cost of financing electrolyser installations. Thursday brings flash purchasing managers’ indices for Germany and the eurozone, giving an early read on industrial health in Nel ASA’s core markets. And on Monday, China publishes industrial production and retail sales figures, adding another variable to the equation for an industry increasingly eyeing Asian demand.

Yet the Norwegian electrolyser maker’s stock is already pricing in a rosier scenario. Nel ASA shares have surged 56% since the start of 2026, with a 15% jump in the past week alone. The Oslo-listed stock closed at 3.22 Norwegian kroner on Friday, well above the consensus analyst target of 2.12 NOK. Berenberg rates it a hold with a fair value of 2.30 NOK, while RBC Capital Markets sits neutral at 3.00 NOK. For a stock with annualised volatility approaching 91%, the gap between market euphoria and analyst caution is unusually wide.

The disconnect becomes starker when you look under the bonnet. Nel’s first-quarter 2026 revenue from customer contracts slipped 5% year on year to 148 million Norwegian kroner (NOK). The company managed to trim its operating loss (EBITDA) to 100 million NOK, but order intake collapsed by 73%, leaving the backlog at just over 1.1 billion NOK. A cash cushion of more than 1.4 billion NOK provides near-term breathing room, but that figure does not yet include the expected EU Innovation Fund grant of up to €135 million.

That grant is earmarked for the industrialisation of Nel’s new pressurised alkaline electrolyser platform, which the company recently unveiled. The technology promises to cut customers’ capital expenditure by as much as 60%. A dedicated production line at Herøya is being built out to one gigawatt of capacity, and the EU subsidy covers a large portion of the eligible costs, reducing the development risk for Nel.

Technically, the rally has not yet pushed the stock into overbought territory. The relative strength index stands at 32, a level that typically signals an oversold condition – an oddity given the recent advance. Momentum traders may interpret this as room for further upside, but the fundamental picture remains fragile.

The real test comes on 15 July, when Nel releases its half-year results. By then management needs to demonstrate that the strong customer interest in simple, safe energy solutions is translating into signed contracts, particularly from data centre operators hungry for round-the-clock clean power. Without concrete large-scale orders, the chasm between market enthusiasm and underlying business performance will be hard to close.

On a broader canvas, the European hydrogen market is showing signs of maturity. In Germany, early interest in the planned hydrogen network has exceeded initial expectations, and collective offtake mechanisms are gaining traction across the continent – a potential solution to the chronic offtake problem that has plagued green fuels. Industry players and analysts expect 2026 to bring more final investment decisions on large projects. How that plays out will depend on the direction of capital costs and industrial partners’ risk appetite, precisely the factors that this week’s Fed minutes and PMI releases will help illuminate.